Patents by Inventor Michael Thierolf

Michael Thierolf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PROTEIN S100A12 AS A MARKER FOR COLORECTAL CANCER
    Publication number: 20170115294
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein S100A12 in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a stool sample, derived from an individual by measuring S100A12 in said sample. Measurement of S100A12 can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: January 6, 2017
    Publication date: April 27, 2017
    Inventors: Norbert Wild, Ursula Garczarek, Andrea Geistanger, Herbert Andres, Marie-Luise Hagmann, Johann Karl, Freidemann Krause, Michael Pfeffer, Wolfgang Rollinger, Michael Tacke, Michael Thierolf
  • USE OF PROTEIN S100A12 AS A MARKER FOR COLORECTAL CANCER
    Publication number: 20150192587
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein S100A12 in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a stool sample, derived from an individual by measuring S100A12 in said sample. Measurement of S100A12 can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: August 20, 2014
    Publication date: July 9, 2015
    Inventors: Norbert Wild, Ursula Garczarek, Andrea Geistanger, Herbert Andres, Marie-Luise Hagmann, Johann Karl, Friedemann Krause, Michael Pfeffer, Wolfgang Rollinger, Michael Tacke, Michael Thierolf
  • CYBP as a marker for lung cancer
    Patent number: 8951738
    Abstract: The present invention relates to the assessment of lung cancer. It discloses the use of protein CYBP in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro using a liquid sample, derived from an individual by measuring CYBP in said sample. Measurement of CYBP can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.
    Type: Grant
    Filed: October 11, 2011
    Date of Patent: February 10, 2015
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Herbert Andres, Johann Karl, Julia Riedlinger, Markus Roessler, Michael Tacke, Michael Thierolf
  • CYBP AS A MARKER FOR LUNG CANCER
    Publication number: 20120196303
    Abstract: The present invention relates to the assessment of lung cancer. It discloses the use of protein CYBP in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro using a liquid sample, derived from an individual by measuring CYBP in said sample. Measurement of CYBP can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.
    Type: Application
    Filed: October 11, 2011
    Publication date: August 2, 2012
    Inventors: Herbert Andres, Johann Karl, Julia Riedlinger, Markus Roessler, Michael Tacke, Michael Thierolf
  • APEX AS A MARKER FOR LUNG CANCER
    Publication number: 20110097756
    Abstract: The present invention relates to the assessment of lung cancer. It discloses the use of protein AP endonuclease (APEX) in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro using a liquid sample derived from an individual by measuring APEX in the sample. Measurement of APEX can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.
    Type: Application
    Filed: September 10, 2009
    Publication date: April 28, 2011
    Inventors: Marie-Luise Hagmann, Johann Karl, Julia Kloeckner, Markus Roessler, Michael Tacke, Michael Thierolf
  • Protein PDX1 as a marker for breast cancer
    Publication number: 20070196844
    Abstract: The present invention relates to the diagnosis of breast cancer. It discloses the use of protein PDX1 (peroxiredoxin 1) in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring PDX1 in said sample. Measurement of PDX1 can, e.g., be used in the early detection or diagnosis of breast cancer.
    Type: Application
    Filed: December 14, 2006
    Publication date: August 23, 2007
    Inventors: Gabriele Pestlin, Herbert Andres, Marie-Luise Hagmann, Johann Karl, Michael Thierolf, Werner Zolg, Peter Berndt, Hanno Langen
  • Protein RS15A as a marker for colorectal cancer
    Publication number: 20070184498
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein RS15A (ribosomal protein S15a) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring RS15A in said sample. Measurement of RS15A can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: December 15, 2006
    Publication date: August 9, 2007
    Inventors: Michael Tacke, Marie-Luise Hagmann, Johann Karl, Michael Pfeffer, Herbert Andres, Michael Thierolf, Norbert Wild, Werner Zolg
  • Protein CBP2 as a marker for colorectal cancer
    Publication number: 20070161062
    Abstract: The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein CBP2 (collagen-binding protein 2) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring CBP2 in said sample. Measurement of CBP2 can, e.g., be used in the early detection or diagnosis of colorectal cancer.
    Type: Application
    Filed: December 15, 2006
    Publication date: July 12, 2007
    Inventors: Michael Tacke, Marie-Luise Hagmann, Johann Karl, Stefan Palme, Michael Pfeffer, Wolfgang Rollinger, Michael Thierolf, Werner Zolg